Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 300 of 581 entries
View as:

IL2 Imaging in Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02922283 Org: User:
Start: 10/20/16 End: 02/14/20 Due: 02/14/21

PREhabilitation of Candidates for REnal Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05489432 Org: User:
Start: 01/23/23 End: 10/31/25 Due: 10/31/26

Tissue Oxygenation During Heart Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01347827 Org: User:
Start: 06/30/11 End: 12/31/11 Due: 12/31/12

Breast Cancer Long-term Outcome of Cardiac Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT01904331 Org: User:
Start: 06/30/13 End: 10/24/17 Due: 10/24/18

Midostaurin in Indolent Systemic Mastocytosis

Phase: N/A Priority: Normal
NCT ID: NCT01920204 Org: User:
Start: 08/31/13 End: 05/31/15 Due: 05/31/16

FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CW

Phase: N/A Priority: Normal
NCT ID: NCT03913806 Org: User:
Start: 05/01/18 End: 01/01/20 Due: 01/01/21

Web-based Screening and Tailored Support

Phase: N/A Priority: Normal
NCT ID: NCT01834521 Org: User:
Start: 01/31/13 End: 12/31/14 Due: 12/31/15

Immunoadsorption in Anti-GBM Glomerulonephritis.

Phase: N/A Priority: Normal
NCT ID: NCT02765789 Org: User:
Start: 06/01/16 End: 07/07/21 Due: 07/07/22

MPDL3280A-imaging-IST-UMCG

Phase: N/A Priority: Normal
NCT ID: NCT02453984 Org: User:
Start: 02/24/16 End: 06/30/24 Due: 06/30/25

Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas

Phase: N/A Priority: Normal
NCT ID: NCT05745857 Org: User:
Start: 05/31/23 End: 12/31/24 Due: 12/31/25

Image Guided Penile Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05376202 Org: User:
Start: 03/07/22 End: 04/14/24 Due: 04/14/25

Trier Social Stress Test in Virtual Reality

Phase: N/A Priority: Normal
NCT ID: NCT05830435 Org: User:
Start: 11/25/22 End: 12/31/23 Due: 12/31/24

Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy

Phase: N/A Priority: Normal
NCT ID: NCT02372864 Org: User:
Start: 02/28/15 End: 12/31/16 Due: 12/31/17

Symptom-driven Maintenance and Reliever Treatment to Prevent Exacerbations in COPD

Phase: N/A Priority: Normal
NCT ID: NCT02477397 Org: User:
Start: 05/01/15 End: 12/15/19 Due: 12/15/20

Fluorescence Guided Surgery in Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02583568 Org: User:
Start: 10/31/15 End: 02/28/17 Due: 02/28/18

Respiratory EMG for NIV Titration in Stable COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT02629055 Org: User:
Start: 11/30/15 End: 06/30/16 Due: 06/30/17

Sodium Thiosulfate to Preserve Cardiac Function in STEMI

Phase: N/A Priority: Normal
NCT ID: NCT02899364 Org: User:
Start: 07/20/18 End: 03/31/23 Due: 03/31/24

Dietary Intervention Trial Targeting Metabolic Syndrome After Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT04698408 Org: User:
Start: 01/31/21 End: 10/31/22 Due: 10/31/23

Adjuvant Breast Cancer Study of the Netherlands Working Party for Autotransplantation in Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00851110 Org: User:
Start: 10/31/04 End: - Due: -

Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01955239 Org: User:
Start: 09/30/13 End: 05/31/17 Due: 05/31/18

Implant Surface Decontamination With 2 % Chlorhexidine in Peri-implantitis Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01852253 Org: User:
Start: 03/31/10 End: 04/30/13 Due: 04/30/14

DIVIT Study Diet and Vitamin Supplementation in Patients With a Neuroendocrine Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03143946 Org: User:
Start: 12/15/16 End: 08/31/19 Due: 08/31/20

Cohort Study on the Effects of Aging in Acquired Brain Injury Patients

Phase: N/A Priority: Normal
NCT ID: NCT05499806 Org: User:
Start: 03/18/22 End: 02/01/24 Due: 02/01/25

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

Phase: N/A Priority: Normal
NCT ID: NCT05076942 Org: User:
Start: 01/01/21 End: 01/01/29 Due: 01/01/30

Prevention and Screening Towards Elimination of Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05234112 Org: User:
Start: 09/15/22 End: 01/31/24 Due: 01/31/25